| tüüp : |
ajaleht |
| interneti link : |
https://pubmed.ncbi.nlm.nih.gov/18032138/ |
|
| uurimisrühmad : |
Nutley - Roche Laboratories |
| Autor : |
Winiarski AP, Infeld MH, Tscherne R, Bachinsky M, Rucki R, Nagano-Mate K. |
| pealkiri : |
Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules. |
| publikatsioon : |
J Am Pharm Assoc ; 47, 6; 747-755. 2007 |
|
| Tõendite tase : |
|
| füüsikaline stabiilsus : |
|
| Keemiline püsivus : |
|
| Muud meetodid : |
|
| Kommentaarid : |
|
ingredientide nimekiri
 Oseltamivir
|
 |
 |
 |
 |
450 mg
Tamiflu® |
|
23-27°C |
 |
| 5 |
 |
|
|
|
|
|
450 mg
Tamiflu® |
|
28-32°C |
|
| 13 |
|
|
|
|
|
|
450 mg
Tamiflu® |
|
3-7°C |
|
| 35 |
|
|
|
|
|
|
450 mg
Tamiflu® |
|
3-7°C |
|
| 35 |
|
|
|
|
 |
|
450 mg
Tamiflu® |
|
23-27°C |
|
| 5 |
|
|
|
|
|
|
450 mg
Tamiflu® |
|
28-32°C |
|
| 13 |
|
|
|
|
|
|
450 mg
Tamiflu® |
|
3-7°C |
|
| 35 |
|
|
|
|
|
|
450 mg
Tamiflu® |
|
3-7°C |
|
| 35 |
|
|
|
|
|
